OLVIG
MYGN icon

Oliver Lagore Vanvalin Investment Group’s Myriad Genetics MYGN Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$763 Buy
+86
New +$508 ﹤0.01% 600
2024
Q4 		$932 Sell
68
-152
-69% -$2.81K ﹤0.01% 615
2024
Q3 		$6.03K Hold
220
– – ﹤0.01% 484
2024
Q2 		$5.38K Hold
220
– – ﹤0.01% 490
2024
Q1 		$4.69K Buy
+220
New +$4.73K ﹤0.01% 518

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's MYGN Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Myriad Genetics (MYGN) in Q2 2025: 86 shares worth $763. The stake represents ﹤0.01% of the portfolio and ranks #600 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in MYGN as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in MYGN in Q1 2024 and has held it in 5 quarters since. The position peaked at $6.03K in Q3 2024. 221 funds tracked by Wall St. Rank hold MYGN as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 86 shares of Myriad Genetics worth $763 as of Q2 2025.
  • Myriad Genetics was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Myriad Genetics made up ﹤0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #600 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Myriad Genetics in Q1 2024 and has held it in 5 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Myriad Genetics position peaked at $6.03K in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.